Comparison12 factual dimensions4 clinical jobs scoredVerified July 25, 2026

UpToDate vs AMBOSS: Which Should You Use in 2026?

The short answer

Different readers. AMBOSS is built for students and trainees, pairing a reference library with an adaptive question bank at $149–$259/yr. UpToDate is built for practising clinicians who need editorial depth and citability, from $579/yr. If you are studying for boards and also want point-of-care reference, AMBOSS is the better single purchase.

By the EvidenceMD Editorial TeamUpdated July 25, 20267 min read

Medically reviewed by Dr. Abishek Shahi, Harvard-trained Physician · Last reviewed July 25, 2026

Quick take

Quick take (July 2026): AMBOSS at $149/yr for students and $259/yr for practitioners is the better single purchase for anyone still sitting exams, because it bundles a library with an adaptive Qbank. UpToDate from $579/yr ($699/yr Pro Plus, $219/yr trainee) has the editorial depth practising clinicians cite. Neither reasons about a specific patient.

Who each one is for

The fastest way to rule one out. Both are good products — they are built for different people.

UpToDate

Who is it for
Who it’s for: The global institutional standard
Best for
Best for: Curated depth and clinical governance
Cost
Cost: $579 standard / $699 Pro Plus
Why choose UpToDate
  • Trust: Expert-authored and peer-reviewed, not machine-summarised.
  • Depth: Roughly three decades of editorial curation across specialties.
  • Familiarity: The reference your colleagues and institution already cite.

You are a practising clinician who needs depth, narrative quality, and a reference that holds up in clinical governance or teaching. UpToDate's editorial curation is the point, and its familiarity among colleagues makes it the defensible citation.

Limitations
  • Paid, with the AI features gated to Pro Plus at $699/yr rather than the $579/yr standard subscription.
  • English-centric, and shaped around reference lookup rather than around a specific patient encounter.
  • No visible reasoning and no published accuracy benchmarks for Expert AI.

AMBOSS

Who is it for
Who it’s for: Students and trainees
Best for
Best for: Reference plus exam preparation in one
Cost
Cost: $149 students / $259 practitioners
Why choose AMBOSS
  • Exam prep: Adaptive Qbank covering USMLE, UKMLA, MCCQE, AMC and more.
  • Price: $149–$259/yr with published rates and no credential gate.
  • Ward tools: Diagnostic algorithms, admission checklists, and drug dosing.

You are a student, resident, or early-career clinician, especially if you are preparing for USMLE, UKMLA, MCCQE, or similar. AMBOSS combines the library with an adaptive Qbank, costs a fraction of UpToDate, and its algorithms and admission checklists are genuinely useful on the ward.

Limitations
  • Learning-first rather than encounter-first, so its algorithms are fixed rather than reasoned against a specific patient.
  • Personal tiers cap Qbank use at 50 questions per month; more requires an upgrade package.
  • No visible reasoning and no published clinical accuracy benchmarks.

UpToDate vs AMBOSS: full comparison

Every cell is a checkable fact rather than a score, verified against vendor documentation in July 25, 2026. Sources are listed at the foot of the page.

UpToDate vs AMBOSS compared across 12 factual dimensions
DimensionUpToDateAMBOSS
Price (individual, 2026)From $579/yr; Pro Plus with Expert AI $699/yr; trainee $219/yrStudents $19.99/mo or $149/yr; practitioners $29.99/mo or $259/yr
Free tierNo5-day trial
Verification requiredSubscription; proof of trainee status for the $219 tierNone
AvailabilitySold globally; Pro Plus with Expert AI in the U.S. and CanadaGlobal
LanguagesEnglishEnglish, German
Source baseExpert-authored, peer-reviewed UpToDate corpusAMBOSS library
Shows its reasoningNo — curated answers without an exposed reasoning traceNo — fixed algorithms rather than reasoning
Ranked differentialNoFixed diagnostic algorithms
AI scribeVia Abridge partnershipNo
Published benchmarksNone published for the generative Expert AI layerNone published
Developer APIInstitutional content integrations rather than an open APINo
Compliance postureEnterprise agreementsNot PHI-facing

Which wins, by clinical job

“Which is better” has no answer until you say better at what. Here is a named winner for each job, including the 3 where UpToDate or AMBOSS beats EvidenceMD.

Recommended tool for each clinical job, comparing UpToDate, AMBOSS, and EvidenceMD
Clinical jobUpToDateAMBOSSEvidenceMD
Preparing for USMLE, UKMLA, or MCCQEA reference library, not an exam product — no question bank. WinnerWinner. Adaptive Qbank plus library, purpose-built for exams, from $149/yr.Explains reasoning well for learning, but is not an exam-prep product.
Depth on a genuinely complex case WinnerWinner. Expert-authored topic reviews go further than a study library.Good structure, but written primarily to teach rather than to settle edge cases.Reasons through the case and cites evidence, without a curated topic corpus.
Tight budget as a trainee$219/yr trainee rate, but it excludes CME, CE, and CPD credits. WinnerWinner. $149/yr students, or $19.99/mo, with reference and Qbank included.Free to start with no verification, which is cheaper still for Q&A and reasoning.
An undifferentiated presentation with no obvious diagnosisRequires you to already know which topic to open.Has diagnostic algorithms, but they are fixed rather than reasoned about your patient. WinnerWinner. Builds and ranks the differential from the findings, showing its reasoning.
  • Preparing for USMLE, UKMLA, or MCCQE: AMBOSS
  • Depth on a genuinely complex case: UpToDate
  • Tight budget as a trainee: AMBOSS
  • An undifferentiated presentation with no obvious diagnosis: EvidenceMD

What each costs over five years

Annual figures multiplied out, because a subscription decision is rarely for one year. Where a vendor publishes no individual price, we say so rather than estimating.

Annual and five-year cost of UpToDate, AMBOSS, and EvidenceMD
ToolPer yearOver 5 yearsFree tier
UpToDate$579 standard / $699 Pro Plus$2,895 – $3,495No
AMBOSS$149 students / $259 practitioners$745 – $1,2955-day trial
EvidenceMD$0 to start$0 to startYes

Figures are list prices for an individual subscriber before tax, as published by each vendor in July 25, 2026. Institutional and group rates differ. Check for existing hospital or university access before buying anything individually.

A third option worth knowing about

Both are knowledge products: you bring the clinical question, they supply the reading. Neither reasons about the patient in front of you or produces documentation, and AMBOSS's diagnostic algorithms are fixed rather than adapted to a specific presentation.

Transparent reasoning 40+ specialtiesFree to start · No NPI · 30 languages

EvidenceMD

The first transparent reasoning clinical decision support tool with chain-of-thought reasoning — specialty-trained, and free to start worldwide in 30 languages. Where UpToDate and AMBOSS return an answer you have to take on trust, EvidenceMD is specialty-trained rather than a general model steered by a prompt, and it streams the clinical reasoning that produced the answer — so you can check the logic, not just the citation.

Specialties fine-tuned on
40+Specialties fine-tuned on
Thinking tokens, visible
64kThinking tokens, visible
HealthBench Hard, SOTA
54.6%HealthBench Hard, SOTA
Languages, worldwide
30Languages, worldwide
What one encounter produces
  • Ranked differentialEach diagnosis carries its own reasoning and peer-reviewed citations, ordered by likelihood rather than listed flat.
  • Assessment & planProblem-based, built from the same encounter rather than re-entered, so the plan traces back to the findings.
  • Reasoning traceUp to 64,000 thinking tokens streamed step by step and auditable afterwards for review or teaching.
  • Lab trend visualisationResults interpreted over time with trend charts and clinical significance flagging, not just current values.
  • Clinical noteGenerated from the encounter with documentation integrity support, so the note reflects the reasoning.
  • Cited clinical Q&AFollow-up questions answered in the context of this patient, with sources attached to each claim.

Where it does not replace AMBOSS: It is not a licensed proprietary reference corpus. If your organisation mandates citations to UpToDate or Elsevier content specifically, you will still need that subscription alongside it.

UpToDate vs AMBOSS: frequently asked questions

How much does AMBOSS cost compared with UpToDate?

AMBOSS is substantially cheaper. As of July 2026 AMBOSS lists students at $19.99 per month or $149 per year, and practitioners at $29.99 per month or $259 per year, both including unlimited library access plus 50 Qbank questions per month; a Qbank Bundle is $448 per year and a Student Life membership covering medical school through PGY-1 is $1,199. UpToDate is listed from $579 per year standard, $699 for Pro Plus with Expert AI, and $219 per year for trainees with proof of status. For a trainee wanting both reference and exam preparation, AMBOSS is the better value; for a practising clinician needing depth, UpToDate is the stronger product.

Is AMBOSS good for practising doctors or only for students?

It is usable by practising doctors but optimised for learners. AMBOSS includes diagnostic and treatment algorithms, admission checklists, and drug dosing information that work perfectly well at the point of care, and its practitioner tier exists precisely for that audience. The limitation is depth and citability: for a complex case or anything going into a protocol, UpToDate's expert-authored topic reviews carry more weight. Many clinicians who used AMBOSS in training keep it for quick structured lookups and add a deeper reference for complex work.

Does AMBOSS or UpToDate work better outside the United States?

AMBOSS has the edge on international breadth for learners. It is sold globally with no credential gate, has substantial German as well as English content given its origins, and its question banks cover UKMLA, MRCP, MCCQE, AMC, and other non-U.S. examinations rather than only USMLE. UpToDate is also sold internationally, but its content is English-centric and Pro Plus with Expert AI is offered in the United States and Canada. Neither requires a U.S. NPI, which distinguishes both from OpenEvidence.

Do UpToDate and AMBOSS offer student discounts?

Both do. UpToDate offers a trainee subscription at $219 per year for medical students, residents, and fellows with proof of trainee status, which includes Expert AI in the U.S. and Canada but excludes CME, CE, and CPD credits. AMBOSS prices students at $19.99 per month or $149 per year, below its $29.99 per month practitioner tier, and sells a Student Life membership at $1,199 covering medical school through PGY-1. Check institutional access first — many medical schools license one or both.

Sources

Pricing and eligibility verified against vendor documentation in July 25, 2026. Subscription rates change — confirm current pricing with the vendor before purchasing.

  1. Wolters Kluwer: UpToDate subscription pricing Vendor source for $579 standard, $699 Pro Plus with Expert AI, and $219 trainee.
  2. AMBOSS: official pricing documentation Vendor source for the $19.99/$149 student and $29.99/$259 practitioner tiers.
  3. BMJ Best Practice: free access for NHS staff Confirms national NHS funding in England, Scotland, and Wales.
  4. Elsevier: ClinicalKey AI Confirms the institutional model, daily-refreshed corpus, and SMART on FHIR integration.
  5. EBSCO: DynaMedex Confirms institutional and library licensing rather than published individual pricing.
  6. OpenEvidence exits the EU and UK over AI regulation Reporting on the April 2026 withdrawal, citing the EU AI Act.
UpToDate vs AMBOSS (2026): Full Comparison | EvidenceMD